[1] Devarbhavi H, Asrani S K, Arab J P, et al.Global burden of liver disease: 2023 update[J]. J Hepatol, 2023, 79(2): 516-537. [2] Long B, Gottlieb M.Emergency medicine updates: spontaneous bacterial peritonitis[J]. Am J Emerg Med, 2023, 70(1): 84-89. [3] 冯冬霞,奚晶,杨振斌,等.乙型肝炎肝硬化并发自发性细菌性腹膜炎患者外周血单个核细胞NLRP3和Caspase-1水平变化及其临床意义探讨[J]. 实用肝脏病杂志, 2023, 26(5): 682-685. [4] Deleuran T, Watson H, Vilstrup H, et al.Spontaneous bacterial peritonitis has no effect on the long-term prognosis of cirrhosis patients with ascites[J]. Ann Hepatol, 2022, 27(4): 100711. [5] Lin Y T, Chen W T, Wu T H, et al.A validated composite score demonstrates potential superiority to MELD-based systems in predicting short-term survival in patients with liver cirrhosis and spontaneous bacterial peritonitis-a preliminary study[J]. Diagnostics (Basel), 2023, 13(15): 2578. [6] 苏娟, 王晓勇, 张惠林.肝硬化患者合并自发性细菌性腹膜炎的危险因素分析[J]. 贵州医药, 2021, 45(9): 1375-1376. [7] Coxeter-Smith C, Al-Adhami A, Alrubaiy L.The usefulness of mayo end-stage liver disease (MELD) and MELD-sodium (MELD-Na) scores for predicting mortality in cirrhotic patients with spontaneous bacterial peritonitis[J]. Cureus, 2023, 15(4): e38343. [8] 项志雄, 宁国强, 邓辉球, 等.PCT、hs-CRP、IL-4诊断及评估肝硬化失代偿期自发性细菌性腹膜炎的效能[J]. 中华医院感染学杂志, 2022, 32(15): 2254-2258. [9] 中华医学会消化病学分会.中国肝硬化临床诊治共识意见[J]. 中华消化杂志, 2023, 43(4): 227-247. [10] Di Martino V, Simone F, Grasso M, et al.Child-Pugh class and not thrombocytopenia impacts the risk of complications of endoscopic band ligation in patients with cirrhosis and high risk varices[J]. J Pers Med, 2023, 13(5): 764. [11] 中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J]. 中华肝脏病杂志, 2017, 25(9): 664-677. [12] 彭小霞, 董碧蓉, 郑晓梅.肝硬化并发自发性细菌性腹膜炎研究进展[J]. 现代临床医学, 2023, 49(6): 458-460,463. [13] Tay P W L,Xiao J,Tan D J H,et al.An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis[J]. Front Med (Lausanne), 2021, 8(1): 693652. [14] 罗楠,李荣宽.肝硬化并发自发性细菌性腹膜炎诊治现状[J]. 实用肝脏病杂志, 2022, 25(5): 616-619. [15] Pimentel R, Gregório C, Figueiredo P.Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review[J]. Acta Gastroenterol Belg, 2021, 84(2): 333-342. [16] 田彩云, 胡晗, 张国远, 等.糖代谢紊乱对肝硬化相关并发症的影响[J]. 临床肝胆病杂志, 2021, 37(5): 1197-1200. [17] 张素媛, 李文雯, 朱娅琪, 等.肝硬化相关肝性脑病患者血清中IL-6、IL-18与血氨水平的相关性分析[J]. 中华全科医学, 2023, 21(2): 288-291. [18] 王京京, 苏云娟, 曹颖, 等.中性粒细胞/淋巴细胞比值的变化对失代偿期肝硬化合并自发性腹膜炎患者不良预后的预测价值[J]. 中国医药, 2021, 16(8): 1204-1208. [19] Meng D, Yang H, Zhang X Q, et al.Heme oxygenase-1 as a predictive marker for spontaneous bacterial peritonitis in cirrhotic patients with ascites[J]. Ann Clin Lab Sci, 2023, 53(3): 448-456. [20] 杨三霞, 戚昉, 吴丽娟,等.肝硬化并发自发性细菌性腹膜炎的危险因素及其与TRAF6基因多态性的关联[J]. 中华医院感染学杂志, 2024, 34(5): 698-702. [21] 吴雪, 张依恋, 李萍, 等.2型糖尿病及空腹胰岛素水平对肝硬化腹水患者发生自发性细菌性腹膜炎的影响[J]. 临床肝胆病杂志, 2022, 38(7): 1548-1553. [22] 谭人杰, 徐佳丽, 孙长峰, 等.肝硬化腹水并发自发性细菌性腹膜炎的临床危险因素分析及诊断模型构建[J]. 重庆医学, 2024, 53(6): 872-876, 882. [23] 赵晨露, 刘素彤, 于中杰, 等.肝硬化腹水并自发性细菌性腹膜炎危险因素分析及诊断模型建立[J]. 中西医结合肝病杂志, 2023, 33(3): 198-201. [24] 许娟, 闫涛涛, 李严锋, 等.ALBI评分联合PCT在肝硬化腹水患者自发性细菌性腹膜炎的预测作用[J]. 胃肠病学和肝病学杂志, 2023,32(1): 85-89. [25] 王爱媛, 张婷, 李春双, 等.糖尿病肾病患者血CD64、Alb、IL-6表达及其与合并肺部感染的关系和预后影响因素[J]. 中国老年学杂志, 2022, 42(3): 547-550. [26] Campello E, Zanetto A, Bulato C, et al.Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure[J]. Liver Int, 2021, 41(10): 2455-2466. [27] 张迎迎, 魏珂乐, 丁鹤, 等.失代偿期肝硬化并发自发性细菌性腹膜炎患者危险因素和PBMC CD36/mTORC1信号通路变化研究[J]. 实用肝脏病杂志, 2024, 27(1): 80-83. [28] 段树静, 何志伟, 郭楠楠, 等.外周血中性粒细胞CD64和血清纤维蛋白原对肝硬化腹水患者并发自发性细菌性腹膜炎的诊断价值[J]. 国际消化病杂志, 2023, 43(2): 103-107. [29] 金文娟, 王莹莹, 钮志林, 等.外周血相关指标与肝硬化腹水并发自发性细菌性腹膜炎的关联分析[J]. 现代消化及介入诊疗, 2022, 27(11): 1443-1447. |